enVVeno Medical Corporation
NVNO
$4.87
$0.265.64%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.50M | -6.23M | -5.64M | -4.96M | -4.99M |
| Total Depreciation and Amortization | 122.00K | 122.00K | 129.00K | 136.00K | 141.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 845.00K | 1.14M | 997.00K | 958.00K | 1.07M |
| Change in Net Operating Assets | -482.00K | -134.00K | 240.00K | -46.00K | 230.00K |
| Cash from Operations | -4.02M | -5.11M | -4.28M | -3.91M | -3.55M |
| Capital Expenditure | -- | -4.00K | -9.00K | -14.00K | -10.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 5.20M | -11.05M | 6.23M | 3.99M | 2.21M |
| Cash from Investing | 5.20M | -11.06M | 6.22M | 3.97M | 2.20M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 0.00 | 13.59M | 0.00 | 46.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 0.00 | 13.59M | 0.00 | 46.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.18M | -16.16M | 15.54M | 66.00K | -1.31M |